Magavern EF - Search Results

1

CYP2C19 Genotype Prevalence and Association With Recurrent Myocardial Infarction in British-South Asians Treated With Clopidogrel.

Magavern EF, Jacobs B, Warren H, Finocchiaro G, Finer S, van Heel DA; Genes & Health Research Team; Smedley D, Caulfield MJ. Magavern EF, et al. JACC Adv. 2023 Sep;2(7):None. doi: 10.1016/j.jacadv.2023.100573. JACC Adv. 2023. PMID: 37808344 Free PMC article.

2

Prevalence and prognostic role of right ventricular involvement in stress-induced cardiomyopathy.

Finocchiaro G, Kobayashi Y, Magavern E, Zhou JQ, Ashley E, Sinagra G, Schnittger I, Knowles JW, Fearon WF, Haddad F, Tremmel JA. Finocchiaro G, et al. J Card Fail. 2015 May;21(5):419-425. doi: 10.1016/j.cardfail.2015.02.001. Epub 2015 Feb 19. J Card Fail. 2015. PMID: 25704104

3

Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment.

Finocchiaro G, Haddad F, Knowles JW, Caleshu C, Pavlovic A, Homburger J, Shmargad Y, Sinagra G, Magavern E, Wong M, Perez M, Schnittger I, Myers J, Froelicher V, Ashley EA. Finocchiaro G, et al. JACC Heart Fail. 2015 May;3(5):408-418. doi: 10.1016/j.jchf.2014.11.011. Epub 2015 Apr 8. JACC Heart Fail. 2015. PMID: 25863972 Free article.

4

Impact of Septal Reduction on Left Atrial Size and Diastole in Hypertrophic Cardiomyopathy.

Finocchiaro G, Haddad F, Kobayashi Y, Lee D, Pavlovic A, Schnittger I, Sinagra G, Magavern E, Myers J, Froelicher V, Knowles JW, Ashley E. Finocchiaro G, et al. Echocardiography. 2016 May;33(5):686-94. doi: 10.1111/echo.13158. Epub 2016 Mar 1. Echocardiography. 2016. PMID: 26926154 Clinical Trial.

5

Ethical considerations for genetic testing in the context of mandated cardiac screening before athletic participation.

Magavern EF, Badalato L, Finocchiaro G, Borry P. Magavern EF, et al. Genet Med. 2017 May;19(5):493-495. doi: 10.1038/gim.2016.146. Epub 2016 Sep 22. Genet Med. 2017. PMID: 27657677 Free article. No abstract available.

6

Time out: ethical reflections on medical disqualification of athletes in the context of mandated pre-participation cardiac screening.

Magavern EF, Finocchiaro G, Sharma S, Papadakis M, Borry P. Magavern EF, et al. Br J Sports Med. 2018 Sep;52(18):1207-1210. doi: 10.1136/bjsports-2017-097524. Epub 2017 Oct 11. Br J Sports Med. 2018. PMID: 29021245 No abstract available.

7

Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy.

Finocchiaro G, Magavern E, Sinagra G, Ashley E, Papadakis M, Tome-Esteban M, Sharma S, Olivotto I. Finocchiaro G, et al. J Am Heart Assoc. 2017 Dec 13;6(12):e007161. doi: 10.1161/JAHA.117.007161. J Am Heart Assoc. 2017. PMID: 29237589 Free PMC article. Review. No abstract available.

8

An Academic Clinician's Road Map to Hypertension Genomics: Recent Advances and Future Directions MMXX.

Magavern EF, Warren HR, Ng FL, Cabrera CP, Munroe PB, Caulfield MJ. Magavern EF, et al. Hypertension. 2021 Feb;77(2):284-295. doi: 10.1161/HYPERTENSIONAHA.120.14535. Epub 2021 Jan 4. Hypertension. 2021. PMID: 33390048 Review.

9

The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ. Magavern EF, et al. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):85-99. doi: 10.1093/ehjcvp/pvab018. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 33638977

10

Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ. Magavern EF, et al. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):100-103. doi: 10.1093/ehjcvp/pvab063. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34463331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page